Apnimed, a sleep disorders drug developer whose lead therapeutic candidate is under FDA review, raised…

Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds…

More than three-quarters of health system and hospital executives plan to expand participation in value-based…

In medical innovation, we prioritize evidence, outcomes, and economics. Metrics such as clinical endpoints, regulatory…

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring…

Pharmaceutical companies often point to slow clinical trial enrollment as a chokepoint for drug development,…